SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
30 hedge funds and large institutions have $6.45M invested in Sophiris Bio, Inc. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
30
Holding in Top 10
–
Calls
$500K
Puts
$356K
Top Buyers
| 1 | +$1.31M | |
| 2 | +$542K | |
| 3 | +$247K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$168K |
| 5 |
BO
BRR OpCo
Columbus,
Ohio
|
+$112K |
Top Sellers
| 1 | -$210K | |
| 2 | -$161K | |
| 3 | -$76K | |
| 4 |
VF
Virtu Financial
New York
|
-$68K |
| 5 |
Bank of New York Mellon
New York
|
-$35.8K |